Growth Metrics

Immuron (IMRN) Shares Outstanding (Weighted Average) (2016 - 2025)

Immuron's quarterly Shares Outstanding (Weighted Average) came in at $888.7 million in Q3 2025, little changed year-on-year from $885.0 million in Q3 2024, and up 1461.44% quarter-over-quarter from $56.9 million in Q2 2025.

Immuron has reported Shares Outstanding (Weighted Average) for 10 years, with the latest figure at $888.7 million in Q3 2025.

  • For the quarter ending Q3 2025, Shares Outstanding (Weighted Average) changed 0.42% year-over-year to $888.7 million; the trailing twelve-month figure through Sep 2025 stood at $888.7 million (changed 0.42% YoY), and the FY2025 full-year result was $888.7 million, changed 0.42% from the prior year.
  • Shares Outstanding (Weighted Average) for Q3 2025 stood at $888.7 million, up from $56.9 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $888.7 million in Q3 2025, with the low at $56.9 million in Q2 2025.
  • Average Shares Outstanding (Weighted Average) over 5 years is $391.1 million, with a median of $62.9 million recorded in 2021.
  • Peak annual rise in Shares Outstanding (Weighted Average) reached 1337.97% in 2023, while the deepest fall reached 93.32% in 2023.
  • Tracing IMRN's Shares Outstanding (Weighted Average) over 5 years: stood at $64.4 million in 2021, then slipped by 9.74% to $58.1 million in 2022, then soared by 890.82% to $575.7 million in 2023, then sank by 89.94% to $57.9 million in 2024, then soared by 1434.09% to $888.7 million in 2025.
  • The last three Shares Outstanding (Weighted Average) figures came in at $888.7 million (Q3 2025), $56.9 million (Q2 2025), and $57.9 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 177,333.76 Bn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 185,491.37 Bn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 100.00 Bn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 55.66 Bn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 118.76 Bn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 254.10 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - 16.04 Bn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 104.00 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 132.89 Mn
10 Immuron 1.27 Bn 1.27 Bn - 888.73 Mn

Historic Data

Download Data 🔒
DateValue
Sep 2, 2025 888.73 Mn
Jun 30, 2025 56.92 Mn
Dec 31, 2024 57.93 Mn
Sep 9, 2024 885.04 Mn
Jun 30, 2024 58.33 Mn
Dec 31, 2023 575.71 Mn
Sep 28, 2023 57.97 Mn
Aug 30, 2023 884.36 Mn
Jun 30, 2023 59.11 Mn
Dec 31, 2022 58.10 Mn
Aug 31, 2022 61.50 Mn
Jun 30, 2022 884.36 Mn
Dec 31, 2021 64.37 Mn
Jun 30, 2021 883.61 Mn
Sep 1, 2020 62.43 Mn
Jun 30, 2020 115.61 Mn
Dec 31, 2019 624.27 Mn
Jun 30, 2019 101.39 Mn
Dec 31, 2018 58.37 Mn
Aug 30, 2018 58.37 Mn
Jun 30, 2018 44.19 Mn
Dec 31, 2017 41.96 Mn
Sep 28, 2017 42.30 Mn
Aug 31, 2017 53.63 Mn
Jun 30, 2017 79.53 Mn
Dec 31, 2016 34.41 Mn
Jun 30, 2016 57.07 Mn